Lonneke Timmers

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Use and Outcomes of Cost-Effectiveness Analyses and Additional Considerations in Pharmaceutical Reimbursement in the Netherlands.

Use and Outcomes of Cost-Effectiveness Analyses and Additional Considerations in Pharmaceutical Reimbursement in the Netherlands.

Journal: PharmacoEconomics

Published: March 23, 2026

Collaborating for Affordable Patient Access to Medicines: Review of the First Decade of the Beneluxa Initiative in Pharmaceutical Policy.

Collaborating for Affordable Patient Access to Medicines: Review of the First Decade of the Beneluxa Initiative in Pharmaceutical Policy.

Journal: Applied health economics and health policy

Published: March 21, 2026

Using Proportional and Absolute Shortfall in Reimbursement Decision-Making in the Netherlands: Implications for Oncology Drugs for Older Patients.

Using Proportional and Absolute Shortfall in Reimbursement Decision-Making in the Netherlands: Implications for Oncology Drugs for Older Patients.

Journal: PharmacoEconomics

Published: March 10, 2026

Coverage with evidence development for medicines with insufficient evidence of clinical benefit: experience from the Netherlands.

Coverage with evidence development for medicines with insufficient evidence of clinical benefit: experience from the Netherlands.

Journal: International journal of technology assessment in health care

Published: November 17, 2025

Rational use of expensive medicines in the Netherlands: strategies to improve effectiveness and reduce burden on patients and society - a narrative review.

Rational use of expensive medicines in the Netherlands: strategies to improve effectiveness and reduce burden on patients and society - a narrative review.

Journal: BMC medicine

Published: August 25, 2025

Cost implications of early treatment discontinuation in cancer: a real-world data analysis.

Cost implications of early treatment discontinuation in cancer: a real-world data analysis.

Journal: The oncologist

Published: August 04, 2025

Regulated markets and rationalised myths: an institutional perspective on value-based purchasing in the Netherlands.

Regulated markets and rationalised myths: an institutional perspective on value-based purchasing in the Netherlands.

Journal: Health economics, policy, and law

Published: June 05, 2025

Preparing for the EU HTA Regulation: Insights from the Dutch Perspective.

Preparing for the EU HTA Regulation: Insights from the Dutch Perspective.

Journal: Journal of market access & health policy

Published: January 31, 2025

Framework for Multistakeholder Patient Registries in the Field of Rare Diseases: Focus on Neurogenetic Diseases.

Framework for Multistakeholder Patient Registries in the Field of Rare Diseases: Focus on Neurogenetic Diseases.

Journal: Neurology

Published: August 22, 2024

Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products.

Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: July 26, 2024

Interchangeability of immune checkpoint inhibitors: an urgent need for action.

Interchangeability of immune checkpoint inhibitors: an urgent need for action.

Journal: The Lancet. Oncology

Published: January 31, 2024

Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®).

Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®).

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: September 27, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026